18-11-2024 |
PM |
|
TWST |
Twist Bioscience Corporation |
2,280 |
-0.59 |
-0.73 |
-0.81 |
Twist Bioscience GAAP EPS of -$0.59 beats by $0.11, revenue of $84.71M beats by $2.05M [11/18/2024 7:20 AM] |
41.29 |
4.40 (11.93%) |
44.44 |
7.55 (20.47%) |
23.00 - 60.90 |
1,696,253 |
1,000,000 |
54,742 |
|
|
02-08-2024 |
PM |
|
TWST |
Twist Bioscience Corporation |
3,250 |
-0.86 |
-0.79 |
-1.01 |
Twist Bioscience reports mixed Q3 results; initiates Q4 and updates FY24 outlook [8/2/2024 7:37 AM] |
42.86 |
-10.19 (-19.21%) |
49.08 |
-3.97 (-7.48%) |
14.42 - 60.90 |
3,434,887 |
960,000 |
11,162 |
|
|
02-05-2024 |
AH |
|
TWST |
Twist Bioscience Corporation |
1,850 |
-0.79 |
-0.84 |
-1.06 |
Twist Bioscience GAAP EPS of -$0.79, revenue of $75.3M [5/2/2024 4:06 PM] |
41.19 |
9.18 (28.68%) |
35.88 |
3.87 (12.09%) |
11.53 - 43.21 |
3,746,272 |
1,070,000 |
1,905 |
|
|
02-02-2024 |
PM |
|
TWST |
Twist Bioscience Corporation |
1,870 |
-0.75 |
-0.80 |
-0.74 |
Twist Bioscience beats top-line and bottom-line estimates; initiates Q2 and raises FY24 outlook [2/2/2024 7:34 AM] |
36.69 |
3.43 (10.31%) |
38.00 |
4.74 (14.25%) |
11.46 - 39.74 |
1,844,219 |
950,000 |
13,709 |
|
|
17-11-2023 |
PM |
|
TWST |
Twist Bioscience Corporation |
1,140 |
-0.81 |
-0.94 |
-0.91 |
Twist Bioscience GAAP EPS of -$0.81 beats by $0.14, revenue of $66.95M beats by $3.5M [11/17/2023 7:36 AM] |
23.99 |
4.92 (25.80%) |
20.98 |
1.91 (10.02%) |
11.46 - 31.51 |
3,795,098 |
1,040,000 |
49,096 |
|
|
04-08-2023 |
PM |
|
TWST |
Twist Bioscience Corporation |
1,220 |
-1.01 |
-1.14 |
-1.08 |
Twist Bioscience GAAP EPS of -$1.01 beats by $0.13, revenue of $63.74M beats by $3.05M [8/4/2023 7:32 AM] |
23.01 |
2.34 (11.32%) |
23.20 |
2.53 (12.24%) |
11.46 - 58.76 |
2,615,200 |
1,080,000 |
27,793 |
|
|
05-05-2023 |
PM |
7:30 AM ET (May 5) |
TWST |
Twist Bioscience Corporation |
653.30 |
-1.06 |
-1.09 |
-1.24 |
Twist Bioscience GAAP EPS of -$1.04 beats by $0.11, revenue of $60.2M beats by $3.61M [5/5/2023 7:38 AM] |
12.87 |
-0.07 (-0.58%) |
12.49 |
-0.45 (-3.48%) |
11.46 - 58.76 |
2,917,380 |
1,400,000 |
74,787 |
|
|
03-02-2023 |
PM |
7:30 AM ET (Feb 3) |
TWST |
Twist Bioscience Corporation |
1,650 |
-0.74 |
-1.09 |
-0.91 |
Twist Bioscience GAAP EPS of -$0.74 beats by $0.36, revenue of $54.24M misses by $0.23M [2/3/2023 7:36 AM] |
25.45 |
-5.45 (-17.64%) |
26.00 |
-4.90 (-15.86%) |
21.78 - 66.15 |
2,771,730 |
1,130,000 |
15,828 |
|
|
18-11-2022 |
PM |
7:30 AM ET (Nov 18) |
TWST |
Twist Bioscience Corporation |
1,590 |
-0.91 |
-1.28 |
-0.84 |
Twist Bioscience GAAP EPS of -$0.91 beats by $0.38, revenue of $57.31M beats by $0.26M, updates FY guidance [11/18/2022 7:37 AM] |
24.78 |
-0.62 (-2.44%) |
28.65 |
3.25 (12.80%) |
23.90 - 119.65 |
3,015,654 |
2,260,000 |
241,225 |
|
|
05-08-2022 |
PM |
7:30 AM ET (Aug 5) |
TWST |
Twist Bioscience Corporation |
2,450 |
-1.08 |
-1.30 |
-0.82 |
Twist Bioscience tops FQ3 estimates, sees FY revenue above prior outlook and consensus [8/5/2022 7:34 AM] |
52.77 |
5.94 (12.68%) |
52.77 |
0.0 (0.00%) |
25.07 - 139.99 |
1,606,541 |
860,000 |
11,252 |
|
|
05-05-2022 |
AH |
4:05 PM ET (May 5) |
TWST |
Twist Bioscience Corporation |
1,760 |
-1.24 |
-1.26 |
-0.78 |
Twist Bioscience GAAP EPS of -$1.13 beats by $0.14, revenue of $48.13M beats by $2.88M [5/5/2022 4:18 PM] |
31.39 |
0.25 (0.80%) |
31.21 |
0.07 (0.22%) |
28.21 - 139.99 |
1,401,530 |
1,090,000 |
308 |
|
|
04-02-2022 |
PM |
7:30 AM ET (Feb 4) |
TWST |
Twist Bioscience Corporation |
3,120 |
-0.91 |
-1.08 |
-0.72 |
Twist Bioscience GAAP EPS of -$0.91, revenue of $42M [2/4/2022 7:31 AM] |
59.50 |
-1.47 (-2.41%) |
62.00 |
1.03 (1.69%) |
48.63 - 199.32 |
1,067,989 |
1,060,000 |
468 |
|
|
22-11-2021 |
PM |
7:35 AM ET (Nov 22) |
TWST |
Twist Bioscience Corporation |
5,530 |
-0.84 |
-0.80 |
-0.54 |
Twist Bioscience EPS beats by $1.63, beats on revenue [11/22/2021 7:36 AM] |
98.24 |
-12.38 (-11.19%) |
105.00 |
-5.62 (-5.08%) |
84.23 - 214.07 |
2,123,605 |
470,000 |
2,714 |
|
|
06-08-2021 |
PM |
7:00 AM ET (Aug 6) |
TWST |
Twist Bioscience Corporation |
5,820 |
-0.82 |
-0.76 |
-0.67 |
Twist Bioscience EPS misses by $0.07, beats on revenue; raises full year guidance [8/6/2021 7:40 AM] |
110.85 |
-13.27 (-10.69%) |
123.00 |
-1.12 (-0.90%) |
53.81 - 214.07 |
764,493 |
450,000 |
616 |
|
|
06-05-2021 |
AH |
4:05 PM ET (May 6) |
TWST |
Twist Bioscience Corporation |
5,530 |
-0.78 |
-0.76 |
-0.85 |
Twist Bioscience EPS misses by $0.02, beats on revenue [5/6/2021 4:11 PM] |
116.74 |
12.44 (11.93%) |
116.74 |
0.0 (0.00%) |
34.16 - 214.07 |
1,608,612 |
740,000 |
9,838 |
|
|
04-02-2021 |
AH |
4:05 PM ET (Feb 4) |
TWST |
Twist Bioscience Corporation |
9,600 |
-0.72 |
-0.74 |
1.00 |
Twist Bioscience EPS beats by $0.01, beats on revenue [2/4/2021 4:07 PM] |
157.79 |
-39.86 (-20.17%) |
156.00 |
-41.65 (-21.07%) |
18.52 - 214.07 |
2,695,448 |
768,785 |
64,954 |
|
|
23-11-2020 |
PM |
Before the open (Nov 23) |
TWST |
Twist Bioscience Corporation |
5,110 |
-0.54 |
-0.71 |
-0.96 |
Twist Bioscience EPS beats by $0.14, beats on revenue [11/23/2020 7:20 AM] |
117.44 |
1.88 (1.63%) |
110.55 |
-5.01 (-4.34%) |
18.52 - 121.40 |
804,708 |
495,536 |
3,453 |
|
|
06-08-2020 |
AH |
4:05 PM ET (Aug 6) |
TWST |
Twist Bioscience Corporation |
2,620 |
-0.67 |
-0.72 |
-0.92 |
Twist Bioscience EPS beats by $0.15, beats on revenue [8/6/2020 4:35 PM] |
64.92 |
-0.78 (-1.19%) |
65.70 |
0.0 (0.00%) |
18.52 - 71.71 |
390,220 |
452,293 |
3,303 |
|
|